Vitamin E and neurodegeneration

Neurobiology of Disease

Volumn 84, Issue , 2015, Pages 78-83

  Ulatowski, Lynn M ^a   Manor, Danny ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; Cerebellum; Memory; Neurodegeneration; Tocopherol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CARRIER PROTEIN; TOCOPHEROL TRANSFER PROTEIN; UNCLASSIFIED DRUG;

ALPHA TOCOPHEROL DEFICIENCY; ATAXIA; BIOLOGICAL FUNCTIONS; BRAIN FUNCTION; BRAIN PROTECTION; CEREBELLUM; COGNITIVE DEFECT; CYSTIC FIBROSIS; DISEASE ASSOCIATION; FRIEDRICH ATAXIA; HUMAN; LEARNING DISORDER; MEMORY DISORDER; NERVE DEGENERATION; NEUROLOGIC DISEASE; NIEMANN PICK DISEASE; NONHUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; REVIEW; TANGIER DISEASE; TREATMENT RESPONSE; ANIMAL; CHEMISTRY; COGNITION; DEGENERATIVE DISEASE; METABOLISM; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; COGNITION; HUMANS; NEURODEGENERATIVE DISEASES; VITAMIN E; VITAMIN E DEFICIENCY;

EID: 84928622749     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.04.002     Document Type: Review

References (108)

1. Andermann E., Remillard G.M., Goyer C., Blitzer L., Andermann F., Barbeau A. Genetic and family studies in Friedreich's ataxia. Can. J. Neurol. Sci. 1976, 3:287-301.
2. Arita M., Sato Y., Miyata A., Tanabe T., Takahashi E., Kayden H.J., Arai H., Inoue K. Human alpha-tocopherol transfer protein: cDNA cloning, expression and chromosomal localization. Biochem. J. 1995, 306(Pt 2):437-443.
3. Arria A.M., Tarter R.E., Warty V., Van Thiel D.H. Vitamin E deficiency and psychomotor dysfunction in adults with primary biliary cirrhosis. Am. J. Clin. Nutr. 1990, 52:383-390.
4. Atkinson J., Epand R.F., Epand R.M. Tocopherols and tocotrienols in membranes: a critical review. Free Radic. Biol. Med. 2008, 44:739-764.
5. Atkinson J., Harroun T., Wassall S.R., Stillwell W., Katsaras J. The location and behavior of alpha-tocopherol in membranes. Mol. Nutr. Food Res. 2010, 54:641-651.
6. Azzi A., Ricciarelli R., Zingg J.M. Non-antioxidant molecular functions of alpha-tocopherol (vitamin E). FEBS Lett. 2002, 519:8-10.
7. Bascunan-Castillo E.C., Erickson R.P., Howison C.M., Hunter R.J., Heidenreich R.H., Hicks C., Trouard T.P., Gillies R.J. Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C. J. Appl. Genet. 2004, 45:461-467.
8. Behl C. Vitamin E protects neurons against oxidative cell death in vitro more effectively than 17-beta estradiol and induces the activity of the transcription factor NF-kappaB. J. Neural Transm. 2000, 107:393-407.
9. Behl C., Davis J., Cole G.M., Schubert D. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem. Biophys. Res. Commun. 1992, 186:944-950.
10. Ben Hamida C., Doerflinger N., Belal S., Linder C., Reutenauer L., Dib C., Gyapay G., Vignal A., Le Paslier D., Cohen D., et al. Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nat. Genet. 1993, 5:195-200.
11. Ben Hamida M., Belal S., Sirugo G., Ben Hamida C., Panayides K., Ionannou P., Beckmann J., Mandel J.L., Hentati F., Koenig M., et al. Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in two inbred Tunisian families. Neurology 1993, 43:2179-2183.
12. Bourre J.M., Clement M. Kinetics of rat peripheral nerve, forebrain and cerebellum alpha-tocopherol depletion: comparison with different organs. J. Nutr. 1991, 121:1204-1207.
13. Brin M.F., Pedley T.A., Lovelace R.E., Emerson R.G., Gouras P., MacKay C., Kayden H.J., Levy J., Baker H. Electrophysiologic features of abetalipoproteinemia: functional consequences of vitamin E deficiency. Neurology 1986, 36:669-673.
14. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., Yu L., Brewer C., Collins J.A., Molhuizen H.O., Loubser O., Ouelette B.F., Fichter K., Ashbourne-Excoffon K.J., Sensen C.W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J., Genest J., Hayden M.R. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 1999, 22:336-345.
15. Buettner G.R. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch. Biochem. Biophys. 1993, 300:535-543.
16. Burck U., Goebel H.H., Kuhlendahl H.D., Meier C., Goebel K.M. Neuromyopathy and vitamin E deficiency in man. Neuropediatrics 1981, 12:267-278.
17. Burton G.W., Traber M.G. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu. Rev. Nutr. 1990, 10:357-382.
18. Burton G.W., Cheeseman K.H., Doba T., Ingold K.U., Slater T.F. Vitamin E as an antioxidant in vitro and in vivo. Ciba Found. Symp. 1983, 101:4-18.
19. Bye A.M., Muller D.P., Wilson J., Wright V.M., Mearns M.B. Symptomatic vitamin E deficiency in cystic fibrosis. Arch. Dis. Child. 1985, 60:162-164.
20. Campuzano V., Montermini L., Molto M.D., Pianese L., Cossee M., Cavalcanti F., Monros E., Rodius F., Duclos F., Monticelli A., Zara F., Canizares J., Koutnikova H., Bidichandani S.I., Gellera C., Brice A., Trouillas P., De Michele G., Filla A., De Frutos R., Palau F., Patel P.I., Di Donato S., Mandel J.L., Cocozza S., Koenig M., Pandolfo M. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996, 271:1423-1427.
21. Carstea E.D., Morris J.A., Coleman K.G., Loftus S.K., Zhang D., Cummings C., Gu J., Rosenfeld M.A., Pavan W.J., Krizman D.B., Nagle J., Polymeropoulos M.H., Sturley S.L., Ioannou Y.A., Higgins M.E., Comly M., Cooney A., Brown A., Kaneski C.R., Blanchette-Mackie E.J., Dwyer N.K., Neufeld E.B., Chang T.Y., Liscum L., Strauss J.F., Ohno K., Zeigler M., Carmi R., Sokol J., Markie D., O'Neill R.R., van Diggelen O.P., Elleder M., Patterson M.C., Brady R.O., Vanier M.T., Pentchev P.G., Tagle D.A. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 1997, 277:228-231.
22. Cavalier L., Ouahchi K., Kayden H.J., Di Donato S., Reutenauer L., Mandel J.L., Koenig M. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am. J. Hum. Genet. 1998, 62:301-310.
23. Chen K., Zhang X., Wei X.P., Qu P., Liu Y.X., Li T.Y. Antioxidant vitamin status during pregnancy in relation to cognitive development in the first two years of life. Early Hum. Dev. 2009, 85:421-427.
24. Cooper J.M., Korlipara L.V., Hart P.E., Bradley J.L., Schapira A.H. Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy. Eur. J. Neurol. 2008, 15:1371-1379.
25. Copp R.P., Wisniewski T., Hentati F., Larnaout A., Ben Hamida M., Kayden H.J. Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders. Brain Res. 1999, 822:80-87.
26. Dysken M.W., Sano M., Asthana S., Vertrees J.E., Pallaki M., Llorente M., Love S., Schellenberg G.D., McCarten J.R., Malphurs J., Prieto S., Chen P., Loreck D.J., Trapp G., Bakshi R.S., Mintzer J.E., Heidebrink J.L., Vidal-Cardona A., Arroyo L.M., Cruz A.R., Zachariah S., Kowall N.W., Chopra M.P., Craft S., Thielke S., Turvey C.L., Woodman C., Monnell K.A., Gordon K., Tomaska J., Segal Y., Peduzzi P.N., Guarino P.D. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 2014, 311:33-44.
27. Elias E., Muller D.P. Use of vitamin E for prevention and treatment of spinocerebellar disorders. Compr. Ther. 1983, 9:56-60.
28. Elias E., Muller D.P., Scott J. Association of spinocerebellar disorders with cystic fibrosis or chronic childhood cholestasis and very low serum vitamin E. Lancet 1981, 2:1319-1321.
29. Farina N., Isaac M.G., Clark A.R., Rusted J., Tabet N. Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst. Rev. 2012, 11:CD002854.
30. Ford E.S., Sowell A. Serum alpha-tocopherol status in the United States population: findings from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 1999, 150:290-300.
31. Fu R., Yanjanin N.M., Bianconi S., Pavan W.J., Porter F.D. Oxidative stress in Niemann-Pick disease, type C. Mol. Genet. Metab. 2010, 101:214-218.
32. Fukuzawa K., Ikebata W., Sohmi K. Location, antioxidant and recycling dynamics of alpha-tocopherol in liposome membranes. J. Nutr. Sci. Vitaminol. (Tokyo) 1993, 39(Suppl.: S9-22).
33. Fulgoni V.L., Keast D.R., Bailey R.L., Dwyer J. Foods, fortificants, and supplements: where do Americans get their nutrients?. J. Nutr. 2011, 141:1847-1854.
34. Geller A., Gilles F., Shwachman H. Degeneration of fasciculus gracilis in cystic fibrosis. Neurology 1977, 27:185-187.
35. German D.C., Quintero E.M., Liang C., Xie C., Dietschy J.M. Degeneration of neurons and glia in the Niemann-Pick C mouse is unrelated to the low-density lipoprotein receptor. Neuroscience 2001, 105:999-1005.
36. German D.C., Quintero E.M., Liang C.L., Ng B., Punia S., Xie C., Dietschy J.M. Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease. J. Comp. Neurol. 2001, 433:415-425.
37. Gohil K., Schock B.C., Chakraborty A.A., Terasawa Y., Raber J., Farese R.V., Packer L., Cross C.E., Traber M.G. Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in alpha-tocopherol transfer protein. Free Radic. Biol. Med. 2003, 35:1343-1354.
38. Gohil K., Godzdanker R., O'Roark E., Schock B.C., Kaini R.R., Packer L., Cross C.E., Traber M.G. Alpha-tocopherol transfer protein deficiency in mice causes multi-organ deregulation of gene networks and behavioral deficits with age. Ann. N. Y. Acad. Sci. 2004, 1031:109-126.
39. Gohil K., Oommen S., Quach H.T., Vasu V.T., Aung H.H., Schock B., Cross C.E., Vatassery G.T. Mice lacking alpha-tocopherol transfer protein gene have severe alpha-tocopherol deficiency in multiple regions of the central nervous system. Brain Res. 2008, 1201:167-176.
40. Gohil K., Vasu V.T., Cross C.E. Dietary alpha-tocopherol and neuromuscular health: search for optimal dose and molecular mechanisms continues!. Mol. Nutr. Food Res. 2010, 54:693-709.
41. Harding A.E., Muller D.P., Thomas P.K., Willison H.J. Spinocerebellar degeneration secondary to chronic intestinal malabsorption: a vitamin E deficiency syndrome. Ann. Neurol. 1982, 12:419-424.
42. Harding A.E., Matthews S., Jones S., Ellis C.J., Booth I.W., Muller D.P. Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. N. Engl. J. Med. 1985, 313:32-35.
43. Higashi Y., Murayama S., Pentchev P.G., Suzuki K. Cerebellar degeneration in the Niemann-Pick type C mouse. Acta Neuropathol. 1993, 85:175-184.
44. Horiguchi M., Arita M., Kaempf-Rotzoll D.E., Tsujimoto M., Inoue K., Arai H. pH-dependent translocation of alpha-tocopherol transfer protein (alpha-TTP) between hepatic cytosol and late endosomes. Genes Cells 2003, 8:789-800.
45. Hosomi A., Arita M., Sato Y., Kiyose C., Ueda T., Igarashi O., Arai H., Inoue K. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 1997, 409:105-108.
46. Hosomi A., Goto K., Kondo H., Iwatsubo T., Yokota T., Ogawa M., Arita M., Aoki J., Arai H., Inoue K. Localization of alpha-tocopherol transfer protein in rat brain. Neurosci. Lett. 1998, 256:159-162.
47. Ingold K.U., Burton G.W., Foster D.O., Hughes L., Lindsay D.A., Webb A. Biokinetics of and discrimination between dietary RRR- and SRR-alpha-tocopherols in the male rat. Lipids 1987, 22:163-172.
48. Jishage K., Arita M., Igarashi K., Iwata T., Watanabe M., Ogawa M., Ueda O., Kamada N., Inoue K., Arai H., Suzuki H. Alpha-tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice. J. Biol. Chem. 2001, 276:1669-1672.
49. Jofre-Monseny L., Huebbe P., Stange I., Boesch-Saadatmandi C., Frank J., Jackson K., Minihane A.M., Rimbach G. Influence of apolipoprotein E genotype and dietary alpha-tocopherol on redox status and C-reactive protein levels in apolipoprotein E3 and E4 targeted replacement mice. Br. J. Nutr. 2008, 100:44-53.
50. Kaempf-Rotzoll D.E., Igarashi K., Aoki J., Jishage K., Suzuki H., Tamai H., Linderkamp O., Arai H. Alpha-tocopherol transfer protein is specifically localized at the implantation site of pregnant mouse uterus. Biol. Reprod. 2002, 67:599-604.
51. Kaempf-Rotzoll D.E., Horiguchi M., Hashiguchi K., Aoki J., Tamai H., Linderkamp O., Arai H. Human placental trophoblast cells express alpha-tocopherol transfer protein. Placenta 2003, 24:439-444.
52. Koscik R.L., Farrell P.M., Kosorok M.R., Zaremba K.M., Laxova A., Lai H.C., Douglas J.A., Rock M.J., Splaingard M.L. Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition. Pediatrics 2004, 113:1549-1558.
53. Koscik R.L., Lai H.J., Laxova A., Zaremba K.M., Kosorok M.R., Douglas J.A., Rock M.J., Splaingard M.L., Farrell P.M. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening. J. Pediatr. 2005, 147:S51-S56.
54. Larnaout A., Belal S., Zouari M., Fki M., Ben Hamida C., Goebel H.H., Ben Hamida M., Hentati F. Friedreich's ataxia with isolated vitamin E deficiency: a neuropathological study of a Tunisian patient. Acta Neuropathol. 1997, 93:633-637.
55. Lebold K.M., Lohr C.V., Barton C.L., Miller G.W., Labut E.M., Tanguay R.L., Traber M.G. Chronic vitamin E deficiency promotes vitamin C deficiency in zebrafish leading to degenerative myopathy and impaired swimming behavior. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2013, 157:382-389.
56. Lemonnier F., Alvarez F., Babin F., Couturier M., Alagille D. Effects of vitamin E treatment in cholestatic children. Adv. Exp. Med. Biol. 1990, 264:143-146.
57. Li D., Devaraj S., Fuller C., Bucala R., Jialal I. Effect of alpha-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies. J. Lipid Res. 1996, 37:1978-1986.
58. Li H., Repa J.J., Valasek M.A., Beltroy E.P., Turley S.D., German D.C., Dietschy J.M. Molecular, anatomical, and biochemical events associated with neurodegeneration in mice with Niemann-Pick type C disease. J. Neuropathol. Exp. Neurol. 2005, 64:323-333.
59. Lim Y., Schock B.C., Gohil K., Leonard S.W., Packer L., Cross C.E., Traber M.G. Gene-nutrient interactions exemplified by the alpha-tocopherol content of tissues from alpha-tocopherol transfer protein-null mice fed different dietary vitamin E concentrations. Ann. N. Y. Acad. Sci. 2004, 1031:328-329.
60. Lloret A., Badia M.C., Mora N.J., Pallardo F.V., Alonso M.D., Vina J. Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental. J. Alzheimers Dis. 2009, 17:143-149.
61. Magalhaes J., Ascensao A., Marques F., Soares J.M., Ferreira R., Neuparth M.J., Duarte J.A. Effect of a high-altitude expedition to a Himalayan peak (Pumori, 7,161 m) on plasma and erythrocyte antioxidant profile. Eur. J. Appl. Physiol. 2005, 93:726-732.
62. Major J.M., Yu K., Chung C.C., Weinstein S.J., Yeager M., Wheeler W., Snyder K., Wright M.E., Virtamo J., Chanock S., Albanes D. Genome-wide association study identifies three common variants associated with serologic response to vitamin E supplementation in men. J. Nutr. 2012, 142:866-871.
63. Major J.M., Yu K., Weinstein S.J., Berndt S.I., Hyland P.L., Yeager M., Chanock S., Albanes D. Genetic variants reflecting higher vitamin e status in men are associated with reduced risk of prostate cancer. J. Nutr. 2014, 144:729-733.
64. Manor D., Morley S. The alpha-tocopherol transfer protein. Vitam. Horm. 2007, 76:45-65.
65. Mariotti C., Gellera C., Rimoldi M., Mineri R., Uziel G., Zorzi G., Pareyson D., Piccolo G., Gambi D., Piacentini S., Squitieri F., Capra R., Castellotti B., Di Donato S. Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurol. Sci. 2004, 25:130-137.
66. Miller G.W., Ulatowski L., Labut E.M., Lebold K.M., Manor D., Atkinson J., Barton C.L., Tanguay R.L., Traber M.G. The alpha-tocopherol transfer protein is essential for vertebrate embryogenesis. PLoS ONE 2012, 7:e47402.
67. Milman U., Blum S., Shapira C., Aronson D., Miller-Lotan R., Anbinder Y., Alshiek J., Bennett L., Kostenko M., Landau M., Keidar S., Levy Y., Khemlin A., Radan A., Levy A.P. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arterioscler. Thromb. Vasc. Biol. 2008, 28:341-347.
68. Muller D.P., Harries J.T., Lloyd J.K. The relative importance of the factors involved in the absorption of vitamin E in children. Gut 1974, 15:966-971.
69. Muller D.P., Lloyd J.K., Wolff O.H. The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption. J. Inherit. Metab. Dis. 1985, 8(Suppl. 1):88-92.
70. Naureckiene S., Sleat D.E., Lackland H., Fensom A., Vanier M.T., Wattiaux R., Jadot M., Lobel P. Identification of HE1 as the second gene of Niemann-Pick C disease. Science 2000, 290:2298-2301.
71. Ouahchi K., Arita M., Kayden H., Hentati F., Ben Hamida M., Sokol R., Arai H., Inoue K., Mandel J.L., Koenig M. Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat. Genet. 1995, 9:141-145.
72. Packer J.E., Slater T.F., Willson R.L. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979, 278:737-738.
73. Panagabko C., Morley S., Hernandez M., Cassolato P., Gordon H., Parsons R., Manor D., Atkinson J. Ligand specificity in the CRAL-TRIO protein family. Biochemistry 2003, 42:6467-6474.
74. Petersen R.C., Thomas R.G., Grundman M., Bennett D., Doody R., Ferris S., Galasko D., Jin S., Kaye J., Levey A., Pfeiffer E., Sano M., van Dyck C.H., Thal L.J., Alzheimer's Disease Cooperative Study G Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 2005, 352:2379-2388.
75. Pfrieger F.W. Cholesterol homeostasis and function in neurons of the central nervous system. Cell. Mol. Life Sci. 2003, 60:1158-1171.
76. Pfrieger F.W. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes?. Bioessays 2003, 25:72-78.
77. Podratz J.L., Rodriguez E.H., Windebank A.J. Antioxidants are necessary for myelination of dorsal root ganglion neurons, in vitro. Glia 2004, 45:54-58.
78. Pollock M., Nukada H., Frith R.W., Simcock J.P., Allpress S. Peripheral neuropathy in Tangier disease. Brain 1983, 106(Pt 4):911-928.
79. Rimbach G., Moehring J., Huebbe P., Lodge J.K. Gene-regulatory activity of alpha-tocopherol. Molecules 2010, 15:1746-1761.
80. Rosenblum J.L., Keating J.P., Prensky A.L., Nelson J.S. A progressive neurologic syndrome in children with chronic liver disease. N. Engl. J. Med. 1981, 304:503-508.
81. Saito Y., Nishio K., Akazawa Y.O., Yamanaka K., Miyama A., Yoshida Y., Noguchi N., Niki E. Cytoprotective effects of vitamin E homologues against glutamate-induced cell death in immature primary cortical neuron cultures: tocopherols and tocotrienols exert similar effects by antioxidant function. Free Radic. Biol. Med. 2010, 49:1542-1549.
82. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 1997, 336:1216-1222.
83. Satel S.L., Riely C.A. Vitamin E deficiency and neurologic dysfunction in children. N. Engl. J. Med. 1986, 314:1389-1390.
84. Sato Y., Hagiwara K., Arai H., Inoue K. Purification and characterization of the alpha-tocopherol transfer protein from rat liver. FEBS Lett. 1991, 288:41-45.
85. Shichiri M., Yoshida Y., Ishida N., Hagihara Y., Iwahashi H., Tamai H., Niki E. alpha-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome. Free Radic. Biol. Med. 2011, 50:1801-1811.
86. Sitrin M.D., Lieberman F., Jensen W.E., Noronha A., Milburn C., Addington W. Vitamin E deficiency and neurologic disease in adults with cystic fibrosis. Ann. Intern. Med. 1987, 107:51-54.
87. Sokol R.J. Vitamin E deficiency and neurologic disease. Annu. Rev. Nutr. 1988, 8:351-373.
88. Sokol R.J., Kayden H.J., Bettis D.B., Traber M.G., Neville H., Ringel S., Wilson W.B., Stumpf D.A. Isolated vitamin E deficiency in the absence of fat malabsorption-familial and sporadic cases: characterization and investigation of causes. J. Lab. Clin. Med. 1988, 111:548-559.
89. Sontag T.J., Parker R.S. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J. Biol. Chem. 2002, 277:25290-25296.
90. Stead R.J., Muller D.P., Matthews S., Hodson M.E., Batten J.C. Effect of abnormal liver function on vitamin E status and supplementation in adults with cystic fibrosis. Gut 1986, 27:714-718.
91. Traber M.G. Vitamin E regulatory mechanisms. Annu. Rev. Nutr. 2007, 27:347-362.
92. Traber M.G., Burton G.W., Ingold K.U., Kayden H.J. RRR- and SRR-alpha-tocopherols are secreted without discrimination in human chylomicrons, but RRR-alpha-tocopherol is preferentially secreted in very low density lipoproteins. J. Lipid Res. 1990, 31:675-685.
93. Traber M.G., Burton G.W., Hughes L., Ingold K.U., Hidaka H., Malloy M., Kane J., Hyams J., Kayden H.J. Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism. J. Lipid Res. 1992, 33:1171-1182.
94. Traber M.G., Sokol R.J., Kohlschutter A., Yokota T., Muller D.P., Dufour R., Kayden H.J. Impaired discrimination between stereoisomers of alpha-tocopherol in patients with familial isolated vitamin E deficiency. J. Lipid Res. 1993, 34:201-210.
95. Ulatowski L., Manor D. Vitamin E trafficking in neurologic health and disease. Annu. Rev. Nutr. 2013, 33:87-103.
96. Ulatowski L., Parker R., Davidson C., Yanjanin N., Kelley T.J., Corey D., Atkinson J., Porter F., Arai H., Walkley S.U., Manor D. Altered vitamin E status in Niemann-Pick type C disease. J. Lipid Res. 2011, 52:1400-1410.
97. Ulatowski L., Dreussi C., Noy N., Barnholtz-Sloan J., Klein E., Manor D. Expression of the alpha-tocopherol transfer protein gene is regulated by oxidative stress and common single-nucleotide polymorphisms. Free Radic. Biol. Med. 2012, 53:2318-2326.
98. Ulatowski L., Dreussi C., Noy N., Barnholtz-Sloan J., Klein E., Manor D. Expression of the alpha-tocopherol transfer protein gene is regulated by oxidative stress and common single-nucleotide polymorphisms. Free Radic. Biol. Med. 2012, 53:2318-2326.
99. Ulatowski L., Parker R., Warrier G., Sultana R., Butterfield D.A., Manor D. Vitamin E is essential for Purkinje neuron integrity. Neuroscience 2014, 260:120-129.
100. Vatassery G.T., Quach H.T., Smith W.E., Santacruz K.S., Roy S. Apolipoprotein e deficiency leads to altered brain uptake of alpha tocopherol injected into lateral cerebral ventricles. Biochim. Biophys. Acta 2007, 1772:797-803.
101. Wang X., Wang H., Xia Y., Jiang H., Shen L., Wang S., Shen R., Huang L., Wang J., Xu Q., Li X., Luo X., Tang B. A neuropathological study at autopsy of early onset spinocerebellar ataxia 6. J. Clin. Neurosci. 2010, 17:751-755.
102. Wang X., Wang H., Xia Y., Jiang H., Shen L., Wang S., Shen R., Xu Q., Luo X., Tang B. Spinocerebellar ataxia type 6: systematic patho-anatomical study reveals different phylogenetically defined regions of the cerebellum and neural pathways undergo different evolutions of the degenerative process. Neuropathology 2010, 30:501-514.
103. Willison H.J., Muller D.P., Matthews S., Jones S., Kriss A., Stead R.J., Hodson M.E., Harding A.E. A study of the relationship between neurological function and serum vitamin E concentrations in patients with cystic fibrosis. J. Neurol. Neurosurg. Psychiatry 1985, 48:1097-1102.
104. Wright M.E., Peters U., Gunter M.J., Moore S.C., Lawson K.A., Yeager M., Weinstein S.J., Snyder K., Virtamo J., Albanes D. Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk. Cancer Res. 2009, 69:1429-1438.
105. Yevenes L.F., Klein A., Castro J.F., Marin T., Leal N., Leighton F., Alvarez A.R., Zanlungo S. Lysosomal vitamin E accumulation in Niemann-Pick type C disease. Biochim. Biophys. Acta 2011, 1822:150-160.
106. Yokota T., Igarashi K., Uchihara T., Jishage K., Tomita H., Inaba A., Li Y., Arita M., Suzuki H., Mizusawa H., Arai H. Delayed-onset ataxia in mice lacking alpha -tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:15185-15190.
107. Yoshida Y., Itoh N., Hayakawa M., Habuchi Y., Saito Y., Tsukamoto Y., Cynshi O., Jishage K., Arai H., Niki E. The role of alpha-tocopherol in motor hypofunction with aging in alpha-tocopherol transfer protein knockout mice as assessed by oxidative stress biomarkers. J. Nutr. Biochem. 2010, 21:66-76.
108. Zampieri S., Mellon S.H., Butters T.D., Nevyjel M., Covey D.F., Bembi B., Dardis A. Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone. J. Cell. Mol. Med. 2009, 13:3786-3796.